US4489055A
(en)
*
|
1978-07-19 |
1984-12-18 |
N.V. Sopar S.A. |
Process for preparing biodegradable submicroscopic particles containing a biologically active substance and their use
|
FR2504408B1
(fr)
*
|
1981-04-24 |
1986-02-14 |
Couvreur Patrick |
Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
|
US4452861A
(en)
*
|
1982-05-20 |
1984-06-05 |
Rca Corporation |
Solid particles encapsulated with cyanoacrylate polymer
|
US4919929A
(en)
*
|
1984-02-01 |
1990-04-24 |
Stolle Research & Development Corporation |
Mammal immunization
|
JPS59163313A
(ja)
*
|
1983-03-09 |
1984-09-14 |
Teijin Ltd |
経鼻投与用ペプチドホルモン類組成物
|
GB8310038D0
(en)
*
|
1983-04-13 |
1983-05-18 |
Amersham Int Plc |
Technetium-99 labelled tin colloid
|
DE3336583A1
(de)
*
|
1983-09-26 |
1985-04-25 |
Udo Dr. 8400 Regensburg Ehrenfeld |
Erzeugnis zur diagnose und therapie von malignen tumoren
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
FR2604903B1
(fr)
*
|
1986-10-08 |
1989-01-13 |
Sopar Sa Nv |
Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
|
JP2664906B2
(ja)
*
|
1987-08-13 |
1997-10-22 |
ストール・リサーチ・アンド・デイベロップメント・コーポレーション |
改良された哺乳類の免疫法
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
US5019400A
(en)
*
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
FR2659554B1
(fr)
|
1990-03-16 |
1994-09-30 |
Oreal |
Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
|
US5078994A
(en)
*
|
1990-04-12 |
1992-01-07 |
Eastman Kodak Company |
Microgel drug delivery system
|
US5288496A
(en)
*
|
1990-05-15 |
1994-02-22 |
Stolle Research & Development Corporation |
Growth promoters for animals
|
US5733566A
(en)
*
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5178882A
(en)
*
|
1990-06-22 |
1993-01-12 |
The Regents Of The University Of California |
Viral decoy vaccine
|
US5219577A
(en)
*
|
1990-06-22 |
1993-06-15 |
The Regents Of The University Of California |
Biologically active composition having a nanocrystalline core
|
US5529914A
(en)
*
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
GB9106686D0
(en)
*
|
1991-03-28 |
1991-05-15 |
Hafslund Nycomed As |
Improvements in or relating to contrast agents
|
ES2034891B1
(es)
*
|
1991-08-08 |
1993-12-16 |
Cusi Lab |
Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
|
GB9200388D0
(en)
*
|
1992-01-09 |
1992-02-26 |
Nycomed As |
Improvements in or relating to contrast agents
|
US5573934A
(en)
*
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
US5643595A
(en)
*
|
1992-11-24 |
1997-07-01 |
Alkermes Controlled Therapeutics Inc. Ii |
Growth promoters for animals
|
US20070117863A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
WO1995026371A1
(en)
*
|
1994-03-28 |
1995-10-05 |
Patrique Limited |
Intermediates for the preparation of poly(cyanoacrylates) and applications of the poly(cyanoacrylates) so prepared
|
US6165988A
(en)
*
|
1995-02-10 |
2000-12-26 |
Christian Noe |
Medicament in particulate form
|
US8333996B2
(en)
|
1995-05-19 |
2012-12-18 |
Etex Corporation |
Calcium phosphate delivery vehicle and adjuvant
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
AU709262B2
(en)
*
|
1995-10-17 |
1999-08-26 |
Board Of Regents, The University Of Texas System |
Insoluble drug delivery
|
US6247995B1
(en)
|
1996-02-06 |
2001-06-19 |
Bruce Bryan |
Bioluminescent novelty items
|
US5876995A
(en)
*
|
1996-02-06 |
1999-03-02 |
Bryan; Bruce |
Bioluminescent novelty items
|
EP0910351A1
(de)
|
1996-06-27 |
1999-04-28 |
G.D. Searle & Co. |
Amphiphile copolymere umfassende teilchen mit einem quervernetzten hüll- und einem inneren kernbereich, verwendbar für pharmazeutische und andere anwendungen
|
US6416960B1
(en)
|
1996-08-08 |
2002-07-09 |
Prolume, Ltd. |
Detection and visualization of neoplastic tissues and other tissues
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US8728536B2
(en)
*
|
1996-10-16 |
2014-05-20 |
Etex Corporation |
Chemotherapeutic composition using nanocrystalline calcium phosphate paste
|
FR2755136B1
(fr)
*
|
1996-10-25 |
1999-01-22 |
Virsol |
Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives et compositions pharmaceutiques les contenant
|
EP1015872B1
(de)
|
1996-12-12 |
2005-03-02 |
Prolume, Ltd. |
Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
|
US5874111A
(en)
*
|
1997-01-07 |
1999-02-23 |
Maitra; Amarnath |
Process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
|
US6120806A
(en)
*
|
1997-06-25 |
2000-09-19 |
Whitmire; David R. |
Oral formulations for controlled release of alcohol deterrents
|
CN100462066C
(zh)
*
|
1997-06-27 |
2009-02-18 |
美国生物科学有限公司 |
药剂的新制剂及其制备和应用方法
|
FR2766368B1
(fr)
*
|
1997-07-24 |
2000-03-31 |
Univ Claude Bernard Lyon |
Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres
|
AU762246B2
(en)
*
|
1998-02-11 |
2003-06-19 |
Rtp Pharma Corporation |
Method and composition for treatment of inflammatory conditions
|
ME00867B
(me)
*
|
1998-03-19 |
2008-08-07 |
Merck Sharp & Dohme |
Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci
|
US6733767B2
(en)
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
EP1925320A3
(de)
|
1998-03-27 |
2008-09-03 |
Prolume, Ltd. |
Luciferasen, fluoreszierende Proteine, Nukleinsäuren zur Kodierung der Luciferasen und der fluoreszierenden Proteine sowie deren Verwendung zur Diagnose, zum Screening mit hohem Durchsatz und zur Behandlung neuartiger Probleme
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
CA2333648C
(en)
|
1998-05-29 |
2008-10-21 |
Rtp Pharma Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
US6162766A
(en)
*
|
1998-05-29 |
2000-12-19 |
3M Innovative Properties Company |
Encapsulated breakers, compositions and methods of use
|
IL141095A0
(en)
|
1998-08-19 |
2002-02-10 |
Rtp Pharma Inc |
Injectable aqueous dispersions of propofol
|
WO2000030616A1
(en)
*
|
1998-11-20 |
2000-06-02 |
Rtp Pharma Inc. |
Dispersible phospholipid stabilized microparticles
|
DE60020382T2
(de)
*
|
1999-09-21 |
2006-01-26 |
Skyepharma Canada Inc., Verdun |
Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
|
US6207193B1
(en)
*
|
1999-12-27 |
2001-03-27 |
Stephen E. Feldman |
Transdermal drug delivery system
|
ES2469642T3
(es)
|
2000-04-20 |
2014-06-18 |
Jagotec Ag |
Procedimiento mejorado para partículas de fármaco insoluble en agua
|
CA2309575A1
(en)
*
|
2000-05-26 |
2001-11-26 |
James E. Guillet |
Internally cross-linked macromolecules
|
JP4969761B2
(ja)
|
2000-08-31 |
2012-07-04 |
オバン・エナジー・リミテッド |
所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
CA2423336C
(en)
*
|
2000-09-20 |
2011-03-08 |
Rtp Pharma Inc. |
Stabilised fibrate microparticles
|
FR2816949B1
(fr)
*
|
2000-11-17 |
2003-11-28 |
Centre Nat Rech Scient |
Copolymere a structure sequencee compose d'un segment saccharidique lie a au moins un segment hydrophobe bioerodable, et particules correspondantes
|
ES2284646T3
(es)
*
|
2001-02-22 |
2007-11-16 |
Jagotec Ag |
Combinaciones de estatina-fibrato con efectos secundarios en ayunas-alimentado reducidos.
|
EP1458362A4
(de)
*
|
2001-11-19 |
2006-01-18 |
Becton Dickinson Co |
Pharmazeutische zusammensetzungen in teilchenform
|
FR2839517A1
(fr)
*
|
2002-05-07 |
2003-11-14 |
Centre Nat Rech Scient |
Nouveaux agents tensioactifs biodegradables de type copolymeres amphiphiles constitues de segments hydrophobes et d'oligo et/ou polysaccharides
|
PL217626B1
(pl)
|
2002-07-18 |
2014-08-29 |
Helix Biopharma Corp |
Kompozycja farmaceutyczna do zastosowania w leczeniu raka
|
DE10315538A1
(de)
*
|
2003-04-04 |
2004-10-21 |
Siemens Ag |
Teilchen mit einer Membran
|
JP5189763B2
(ja)
*
|
2003-04-11 |
2013-04-24 |
エテックス コーポレーション |
骨誘導性骨材料
|
US7611630B2
(en)
*
|
2004-03-30 |
2009-11-03 |
Bend Research, Inc. |
Method and device for evaluation of pharmaceutical compositions
|
KR101218454B1
(ko)
*
|
2004-04-15 |
2013-01-04 |
에텍스 코포레이션 |
세팅 지연 칼슘 포스페이트 페이스트
|
FR2872703B1
(fr)
*
|
2004-07-07 |
2006-10-06 |
Ethypharm Sa |
Nanoparticules polymeriques composites
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
DK1973552T3
(en)
*
|
2005-12-23 |
2017-08-07 |
Ajay Gupta |
Parenteral nutritional composition containing iron
|
WO2007124372A2
(en)
*
|
2006-04-20 |
2007-11-01 |
Transport Pharmaceuticals, Inc. |
Pharmaceutical formulations for iontophoretic methotrexate delivery
|
US20080003215A1
(en)
*
|
2006-06-13 |
2008-01-03 |
Bayrock Dennis P |
Use of pre-dissolved pristinamycin-type and polyether ionophore type antimicrobial agents in the production of ethanol
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
US9289196B2
(en)
|
2006-12-12 |
2016-03-22 |
Cook Medical Technologies Llc |
Hemostatic substance with a coating
|
WO2008125940A2
(en)
*
|
2007-04-17 |
2008-10-23 |
Pfizer Products Inc. |
Nanoparticles comprising non-crystalline drug
|
CA2683712A1
(en)
*
|
2007-04-20 |
2009-01-15 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions
|
US8703204B2
(en)
*
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
WO2008135852A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising nanoparticles and casein
|
US8309129B2
(en)
*
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
EP2162120B1
(de)
*
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
EP2178518A2
(de)
*
|
2007-07-13 |
2010-04-28 |
Bend Research, Inc |
Nanopartikel mit ionisierbaren und schwach wasserlöslichen zellulose-polymeren
|
US20090061009A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Joseph Schwarz |
Composition and Method of Treatment of Bacterial Infections
|
FR2921660B1
(fr)
|
2007-10-01 |
2015-09-25 |
Centre Nat Rech Scient |
Nanoparticules hybrides organiques inorganiques a base de carboxylates de fer.
|
FR2921661B1
(fr)
*
|
2007-10-01 |
2013-05-31 |
Centre Nat Rech Scient |
Solide hybride organique inorganique a surface modifiee.
|
EP2742875B1
(de)
*
|
2007-11-14 |
2016-02-24 |
Adhezion Biomedical, LLC |
Cyanoacrylgewebehaftstoffe
|
US9724362B2
(en)
*
|
2007-12-06 |
2017-08-08 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
WO2009073216A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
|
CA2730745A1
(en)
|
2008-07-17 |
2010-01-21 |
Merial Limited |
Long-acting injectable analgesic formulations for animals
|
FR2991325B1
(fr)
|
2012-05-31 |
2015-01-16 |
Centre Nat Rech Scient |
Solide hybride organique inorganique ameliore a surface externe modifiee
|
AU2016210551B2
(en)
|
2015-01-23 |
2019-03-07 |
Helix Biopharma Corp. |
Antibody-urease conjugates for therapeutic purposes
|